Genevieve Boucher
Montreal, QC H3T1J4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.
Journal: Biomarker research
Published: November 06, 2024
Immunotherapeutic targeting of surfaceome heterogeneity in AML.
Journal: Cell reports
Published: October 05, 2023
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.
Journal: Blood advances
Published: August 30, 2021
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
Journal: Blood
Published: September 16, 2019
Genetic characterization of ABT-199 sensitivity in human AML.
Journal: Leukemia
Published: March 06, 2019
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
Journal: Cancer cell
Published: June 30, 2018
Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2017
MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.
Journal: Nucleic acids research
Published: October 25, 2016
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.
Journal: Blood
Published: March 13, 2016
Last Updated: 09/26/2026